Table 4

HRs and 95% CIs for selected arterial and venous thromboses among MGUS patients versus matched controls, stratified by MGUS isotype

Type of thrombosisIgG/IgA MGUS
IgM MGUS
1-year follow-up
5-year follow-up
1-year follow-up
5-year follow-up
MGUS patients (n = 2724)Controls (n = 10 348)HR* (95% CI)MGUS patientsControlsHR* (95% CI)MGUS patients (n = 530)Controls (n = 2017)HR* (95% CI)MGUS patientsControlsHR* (95% CI)
Arterial thrombosis 139 337 1.6 (1.3-1.9) 359 1175 1.2 (1.1-1.4) 24 91 1.0 (0.6-1.6) 63 287 0.8 (0.6-1.1) 
Venous thrombosis 35 32 4.2 (2.6-6.8) 88 168 2.1 (1.6-2.7) 11 1.0 (0.3-3.7) 32 1.0 (0.5-2.2) 
Type of thrombosisIgG/IgA MGUS
IgM MGUS
1-year follow-up
5-year follow-up
1-year follow-up
5-year follow-up
MGUS patients (n = 2724)Controls (n = 10 348)HR* (95% CI)MGUS patientsControlsHR* (95% CI)MGUS patients (n = 530)Controls (n = 2017)HR* (95% CI)MGUS patientsControlsHR* (95% CI)
Arterial thrombosis 139 337 1.6 (1.3-1.9) 359 1175 1.2 (1.1-1.4) 24 91 1.0 (0.6-1.6) 63 287 0.8 (0.6-1.1) 
Venous thrombosis 35 32 4.2 (2.6-6.8) 88 168 2.1 (1.6-2.7) 11 1.0 (0.3-3.7) 32 1.0 (0.5-2.2) 
*

Adjusted for age, sex, and calendar period.

Angina pectoris, unstable angina, myocardial infarction, transient ischemic attack, and cerebral infarction.

DVT and PE.

or Create an Account

Close Modal
Close Modal